Advertisement

Breast Cancer Research

, 20:68 | Cite as

Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

  • Ma’anit Shapira
  • Eli Kakiashvili
  • Tzur Rosenberg
  • Dan D. Hershko
Open Access
Correction

Correction

After the publication of this work [1], an error was noticed in Fig. 2b, Fig. 3a and Fig. 5b. The Skp1 loading control was accidentally duplicated. We apologize for this error, which did not affect any of the interpretations or conclusions of the article.

Reference

  1. 1.
    Hershko D, et al. The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells. Breast Cancer Res. 2006;8(4):R46.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Ma’anit Shapira
    • 1
    • 2
  • Eli Kakiashvili
    • 3
  • Tzur Rosenberg
    • 2
  • Dan D. Hershko
    • 1
    • 2
    • 4
  1. 1.Department of Surgery ARambam Medical CenterHaifaIsrael
  2. 2.Technion – Israel Institute of TechnologyHaifaIsrael
  3. 3.Department of Surgery BRambam Medical CenterHaifaIsrael
  4. 4.Breast Health Institute, Rambam Medical CenterHaifaIsrael

Personalised recommendations